Navigation Links
Renaissance Health Publishing, LLC Warns the Public that ConsumerLab.com is Not Independent and Labels the 'CL Seal of Approval' a Worthless, Paid-For Advertising Gimmick
Date:1/24/2008

BOCA RATON, Fla., Jan. 24 /PRNewswire/ -- Renaissance Health Publishing, LLC is publicly disputing ConsumerLab.com, LLC's (CL) claims that they are a "leading provider of independent test results and information to help consumers and healthcare professionals evaluate health, wellness, and nutrition products," chiefly objecting to ConsumerLab.com's self-portrayal of being independent, and is warning consumers that it believes that the "CL Seal of Approval" is nothing more than an advertising gimmick.

"I simply don't believe the repeated advertising and editorial assertions of ConsumerLab.com that it is independent," says James DiGeorgia, CEO of Renaissance Health Publishing, LLC. "In my opinion, ConsumerLab.com's representation that it is an independent consumer advocate is a fraudulent, deceptive and unfair practice constructed specifically to mislead consumers."

Renaissance Health believes that consumers are being duped by ConsumerLab.com in a number of ways:

-- The very name ConsumerLab.com is misleading, as they are not a lab

-- ConsumerLab.com refuses to open their records of who has paid for (and

passed and failed) testing for the "CL Seal of Approval"

-- ConsumerLab.com issues sensationalized "name and shame" releases,

without checking for current formulations and without clearly

disclosing associations with companies that have paid for advertising

and their services

-- ConsumerLab.com is not independent, as they charge consumers for their

"impartial" reports, while at the same time accepting advertising

revenue from companies they test

"The very name of the company chosen by its owners is deceptive. They are not a lab and outsource testing to commercial labs and charge up to eight times what other commercial labs charge. If the contents of the tested product match the label you get a report and the use of their CL Seal of Approval," says DiGeorgia.

Renaissance Health has repeatedly asked that ConsumerLab.com open their records for inspection.

"ConsumerLab.com should have to show how many companies and individuals have submitted products under its voluntary review program for a CL Seal of Approval-and paid the $3,000 to $4,000 they charge-and see how many of these products did and didn't eventually pass," says DiGeorgia.

"ConsumerLab.com tested our old formulation of Revatrol that hasn't been available for more than nine months. What reputable testing agency would test such an old, out-of-date product, without double-checking to ensure they're testing the current product?" asks an exasperated DiGeorgia.

When ConsumerLab.com was made aware of the fact that they tested a discontinued formulation, they asked Renaissance Health to pay a sizeable fee to test the current product.

"They had the audacity to ask us to pay $3,000 to $4,000 to test the current formulation - the very formulation they should have tested from the start; the formulation that had been on the market for more than nine months at the time of their testing.

"We had the current formulation of Revatrol recently tested by a commercial laboratory not affiliated with our manufacturer. And we quickly discovered that not only does our formulation include everything claimed on the label and in the advertising, but we give our customers much more of the Trans-Resveratrol, Resveratrol, Alpha Lipoic Acid, Acetyl-L-Carnitine and Quercetin than what's promised.

"Best of all our formulation gives our customers a 95% OPC. Thus, despite the fact that our product has more of everything we claim and is by far the most complete formulation, Revatrol won't ever receive a 'CL Seal of Approval' because we won't pay," says DiGeorgia.

Renaissance Health also says that claims of independence by ConsumerLab.com are compromised by its revenue model.

"I believe that any company that both charges consumers for its ratings and sells advertising to the parent companies of the products they are currently testing or may test in the future is NOT independent, and we're not the first to recognize this farce," suggests DiGeorgia.

DiGeorgia points to the Council for Responsible Nutrition (CRN), who, in 2005, asked the Federal Trade Commission to investigate ConsumerLab.com for deceptive business practices as one such example.

CRN pointed out that in the very letter ConsumerLab.com sent to the FTC in an attempt to defend its business, ConsumerLab.com "admits to the very business practices about which we are complaining, but in a manner so oblique that only those of us who fully understand the ConsumerLab business plan will comprehend the admission," reports DiGeorgia.

Additionally, in August 2006, Marc Ullman, a New York City attorney and who also manages FYI Newsletter, which highlights legal and regulatory issues concerning the Natural Product Industry, wrote:

"Since its inception, ConsumerLab.com has succeeded in presenting itself

to the mainstream media as an impartial watchdog of the dietary

supplement industry. It has managed to accomplish this despite the

fundamentally flawed nature of its basic business plan - ConsumerLab.com

solicits money from both the industry it purports to police and the

consumers it purports to protect. (Not to mention that it is not a lab

either.)"

"ConsumerLab.com has now taken the conflict of interest one step further, and we believe has completely exposed the absurdity of its claim to independence," says Michael London, general manager of Renaissance Health Publishing, LLC.

"They're currently allowing a competitor of ours to advertise on the ConsumerLab.com website. And by allowing a link back to the competitor's Web site ConsumerLab.com is allowing this competitor-who we have been in litigation with for more than a year-to use the misleading and out-of-date ConsumerLab.com study of our product to deceive consumers."

Renaissance Health believes that ConsumerLab.com is being punitive, and has allowed its competitor to take advantage of a misleading report because Renaissance Health has asked extremely tough credibility questions of ConsumerLab.com publicly, which they have yet to answer. Those questions include:

-- Question 1: Is ConsumerLab.com really a lab or does the company ALWAYS

contract outside labs to conduct product testing?

-- Question 2: Will ConsumerLab.com please make public all monies received

from all companies and persons connected with any and all products they

have tested?

-- Question 3: Why is ConsumerLab.com a for-profit company instead of a

not-for-profit?

Renaissance Health has stated that it will not allow ConsumerLab.com or its competitor to get away with misleading the public, and that it plans on continuing to exercise its legal rights to try and put an end to this type of abuse of the consumer trust.

Renaissance Health's Revatrol product is so strong that its principal competitor simply can't compete. The competitor has been discounting its product (selling 12 for the price of eight) while Renaissance Health can't manufacture Revatrol fast enough to keep up with the growing demand.

"They make two big claims about their product, both of which are based on flawed logic," says DiGeorgia.

The competitor claims a shelf-life of more than two (2) years and that a special capsule makes that long shelf-life possible.

"Anyone taking supplements should stick with fresh product. We can't make Revatrol fast enough to keep our supply more than 90 days-and we're ordering in batches of 50,000 units at a time! Who cares about the capsule, when you should be taking a fresh supplement," says DiGeorgia.

"The proof is in the numbers: we keep selling out our inventory," says Michael London operations manager of Renaissance Health. "Our sales continue to grow as tens of thousands of eager buyers are inundating us with orders and re-orders. The good guys are winning and it's making the competition crazy. Our testing proves that Revatrol delivers much more than our competitor, for the same money or less."

Renaissance Health says any competitor is welcome to what they and the other professionals in the Health Supplement and Vitamin Industry consider a worthless ConsumerLab.com Seal of Approval.

"Boasting about a quality seal that you pay for as being a reason to buy our competitor's product smacks of pure desperation," concludes DiGeorgia.

For more information on Revatrol and its potent benefits, please visit http://www.revatrol.com/ or call our knowledgeable representatives at 1-866-482-6678.


'/>"/>
SOURCE Renaissance Health Publishing, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Renaissance Health Publishing, LLC Asks Key Credibility Questions of ConsumerLab.com
2. ConsumerLab.com Study On Revatrol NOT Based on Current Formulation - the Revatrol Sample Used Was More Than Nine Months Out-Of-Date, says Renaissance Health Publishing
3. Gentiva(R) Health Services Promotes Boelsen to Senior Vice President, CareCentrix(R)
4. Avamere Health Systems Announces New President of Signature Home Health
5. Controlling health destiny
6. The Health Trust Announces $30 Million Investment Towards Making Silicon Valley Healthiest Region in America
7. Healthcare Workers Skeptical of Planning Process for St. Lukes
8. From Research to Practice: Healthfitness, Eastman Chemical Company Case Study Demonstrates Real-World Health Gains and Productivity Savings
9. AMA on the State of Health Care in Advance of the Presidential State of the Union Address
10. Boston Research Summit gathers 100 health care leaders on decision making
11. Accuro Healthcare Solutions, Inc. Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology: